Literature DB >> 12605268

Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring.

Gysbert van Setten1, Miltos Aspiotis, Timothy D Blalock, Gary Grotendorst, Gregory Schultz.   

Abstract

BACKGROUND: Various growth factors have been detected in pterygium and been associated with its vasculogenesis. The basic pathophysiological mechanisms responsible especially for the fibrotic activity in pterygium are, however, not yet known. Connective tissue growth factor (CTGF) has been shown to be substantially involved in various processes of fibrosis. We report on the presence of CTGF in pterygium and its simultaneous presence with vascular endothelial growth factor (VEGF).
METHODS: Samples of pterygium were collected during surgery with informed consent of the patients. Specific, non-commercial primary antibodies against CTGF were used to detect CTGF using immunohistochemistry. Specificity of antibodies was confirmed with Western-blot analysis. The same specimens were stained with commercial antibodies for VEGF. Additionally RT-PCR analysis was performed from pterygium samples.
RESULTS: CTGF was detected in the epithelium of all samples as well as in some stromal keratocytes. The RT-PCR confirmed the identity of CTGF in these samples. The staining pattern differed slightly from that of VEGF, which was detected in all samples. The control sections were negative.
CONCLUSION: CTGF is present in the epithelium of a majority of pterygia and probably contributes to fibrosis. Simultaneous presence with VEGF suggests growth factor interaction and possible involvement in apoptotic dysregulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12605268     DOI: 10.1007/s00417-002-0589-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

Review 1.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

2.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

3.  Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.

Authors:  S L Ho; G F Dogar; J Wang; J Crean; Q D Wu; N Oliver; S Weitz; A Murray; P E Cleary; C O'Brien
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

4.  Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.

Authors:  Jie Zhang; Mingchang Zhang; Xiaoqing Li; Tian Zheng; Ge Mu; Wei Liu; Huatao Xie; Xin Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

5.  Metabolomics analysis in pterygium tissue.

Authors:  Ayhan Saglik; Ismail Koyuncu; Ataman Gonel; Hamza Yalcin; Fatih Mehmet Adibelli; Muslum Toptan
Journal:  Int Ophthalmol       Date:  2019-01-08       Impact factor: 2.031

6.  Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro.

Authors:  Osamu Yamanaka; Shizuya Saika; Kazuo Ikeda; Ken-Ichi Miyazaki; Ai Kitano; Yoshitaka Ohnishi
Journal:  Jpn J Ophthalmol       Date:  2008-03-28       Impact factor: 2.447

7.  Corneal melting two weeks after pterygium excision with topical mitomycin C: successfully treated with lamellar keratoplasty and amnion membrane transplantation.

Authors:  Moreno Menghini; Stephanie L Watson; Martina M Bosch
Journal:  Case Rep Ophthalmol       Date:  2012-01-31

8.  Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro.

Authors:  Axel Seher; Joachim Nickel; Thomas D Mueller; Susanne Kneitz; Susanne Gebhardt; Tobias Meyer ter Vehn; Guenther Schlunck; Walter Sebald
Journal:  Mol Vis       Date:  2011-01-08       Impact factor: 2.367

9.  The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery.

Authors:  Ece Turan-Vural; Banu Torun-Acar; S Argun Kivanc; Suphi Acar
Journal:  Clin Ophthalmol       Date:  2011-06-29

10.  Expression of survivin protein in pterygium and relationship with oxidative DNA damage.

Authors:  C Maxia; M T Perra; P Demurtas; L Minerba; D Murtas; F Piras; A Corbu; D C Gotuzzo; R G Cabrera; D Ribatti; P Sirigu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.